Viewing Study NCT01773018


Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2026-03-09 @ 8:28 PM
Study NCT ID: NCT01773018
Status: COMPLETED
Last Update Posted: 2016-06-01
First Post: 2013-01-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors
Sponsor: Hutchison Medipharma Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module